APO Research
Talk to an analyst

APO RESEARCH · REPORT

Host Defense Peptides (HDPs)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Host Defense Peptides (HDPs) Market Outlook and Growth Opportunities 2026

2 January 2026195 pages

Choose your research edition.

Industry ResearchHost Defense Peptides (HDPs) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Host Defense Peptides (HDPs) Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Host Defense Peptides (HDPs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Host Defense Peptides (HDPs) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Host Defense Peptides (HDPs) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Host Defense Peptides (HDPs) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Host Defense Peptides (HDPs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Host Defense Peptides (HDPs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Host Defense Peptides (HDPs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Host Defense Peptides (HDPs) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Host Defense Peptides (HDPs) market include Zhongnong Yingtai Biotechnology, Chinese Peptide, Sunsmile, Ruixing Biotechnology, Phoenix Biotech, Ontores, Novabiotics, Hycult Biotech and Glam Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Host Defense Peptides (HDPs) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Host Defense Peptides (HDPs) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Host Defense Peptides (HDPs) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Host Defense Peptides (HDPs) market size, projected growth trends, production technologies, key applications, and end-use industries.

Host Defense Peptides (HDPs) Segment by Company

Zhongnong Yingtai Biotechnology

Chinese Peptide

Sunsmile

Ruixing Biotechnology

Phoenix Biotech

Ontores

Novabiotics

Hycult Biotech

Glam Technology

GenScript

AnaSpec

AMP Biotech

Host Defense Peptides (HDPs) Segment by Type

Plant Defense Peptides

Bacterial Defense Peptides

Animal Defense Peptides

Host Defense Peptides (HDPs) Segment by Application

Pharmaceuticals

Feed Additives

Others

Host Defense Peptides (HDPs) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Host Defense Peptides (HDPs) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Host Defense Peptides (HDPs) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Host Defense Peptides (HDPs) significant trends, drivers, influence factors in global and regions.

6. To analyze Host Defense Peptides (HDPs) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Host Defense Peptides (HDPs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Host Defense Peptides (HDPs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Host Defense Peptides (HDPs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Host Defense Peptides (HDPs) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Host Defense Peptides (HDPs) industry.

Chapter 3: Detailed analysis of Host Defense Peptides (HDPs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Host Defense Peptides (HDPs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Host Defense Peptides (HDPs) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Host Defense Peptides (HDPs) Industry Trends Table 2. Host Defense Peptides (HDPs) Industry Drivers Table 3. Host Defense Peptides (HDPs) Industry Opportunities and Challenges Table 4. Host Defense Peptides (HDPs) Industry Restraints Table 5. Global Host Defense Peptides (HDPs) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Host Defense Peptides (HDPs) Revenue Share by Company (2021-2026) Table 7. Global Host Defense Peptides (HDPs) Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Host Defense Peptides (HDPs) Sales Volume Share by Company (2021-2026) Table 9. Global Host Defense Peptides (HDPs) Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Host Defense Peptides (HDPs) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Host Defense Peptides (HDPs) Key Company Manufacturing Base & Headquarters Table 12. Global Host Defense Peptides (HDPs) Company, Product Type & Application Table 13. Global Host Defense Peptides (HDPs) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Host Defense Peptides (HDPs) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Plant Defense Peptides Table 18. Significant Companies of Bacterial Defense Peptides Table 19. Significant Companies of Animal Defense Peptides Table 20. Global Host Defense Peptides (HDPs) Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Host Defense Peptides (HDPs) Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Host Defense Peptides (HDPs) Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Host Defense Peptides (HDPs) Sales Volume Share by Type (2021-2026) Table 24. Global Host Defense Peptides (HDPs) Sales Volume Share by Type (2027-2032) Table 25. Global Host Defense Peptides (HDPs) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Host Defense Peptides (HDPs) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Host Defense Peptides (HDPs) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Host Defense Peptides (HDPs) Sales Value Share by Type (2021-2026) Table 29. Global Host Defense Peptides (HDPs) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Pharmaceuticals Table 31. Significant Companies of Feed Additives Table 32. Significant Companies of Others Table 33. Global Host Defense Peptides (HDPs) Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Host Defense Peptides (HDPs) Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Host Defense Peptides (HDPs) Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Host Defense Peptides (HDPs) Sales Volume Share by Application (2021-2026) Table 37. Global Host Defense Peptides (HDPs) Sales Volume Share by Application (2027-2032) Table 38. Global Host Defense Peptides (HDPs) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Host Defense Peptides (HDPs) Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Host Defense Peptides (HDPs) Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Host Defense Peptides (HDPs) Sales Value Share by Application (2021-2026) Table 42. Global Host Defense Peptides (HDPs) Sales Value Share by Application (2027-2032) Table 43. Global Host Defense Peptides (HDPs) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Host Defense Peptides (HDPs) Sales by Region (2021-2026) & (K Units) Table 45. Global Host Defense Peptides (HDPs) Sales Market Share by Region (2021-2026) Table 46. Global Host Defense Peptides (HDPs) Sales by Region (2027-2032) & (K Units) Table 47. Global Host Defense Peptides (HDPs) Sales Market Share by Region (2027-2032) Table 48. Global Host Defense Peptides (HDPs) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Host Defense Peptides (HDPs) Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Host Defense Peptides (HDPs) Sales Value Share by Region (2021-2026) Table 51. Global Host Defense Peptides (HDPs) Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Host Defense Peptides (HDPs) Sales Value Share by Region (2027-2032) Table 53. Global Host Defense Peptides (HDPs) Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Host Defense Peptides (HDPs) Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Host Defense Peptides (HDPs) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Host Defense Peptides (HDPs) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Host Defense Peptides (HDPs) Sales by Country (2021-2026) & (K Units) Table 58. Global Host Defense Peptides (HDPs) Sales Market Share by Country (2021-2026) Table 59. Global Host Defense Peptides (HDPs) Sales by Country (2027-2032) & (K Units) Table 60. Global Host Defense Peptides (HDPs) Sales Market Share by Country (2027-2032) Table 61. Global Host Defense Peptides (HDPs) Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Host Defense Peptides (HDPs) Sales Value Market Share by Country (2021-2026) Table 63. Global Host Defense Peptides (HDPs) Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Host Defense Peptides (HDPs) Sales Value Market Share by Country (2027-2032) Table 65. Zhongnong Yingtai Biotechnology Company Information Table 66. Zhongnong Yingtai Biotechnology Business Overview Table 67. Zhongnong Yingtai Biotechnology Host Defense Peptides (HDPs) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Zhongnong Yingtai Biotechnology Host Defense Peptides (HDPs) Product Portfolio Table 69. Zhongnong Yingtai Biotechnology Recent Development Table 70. Chinese Peptide Company Information Table 71. Chinese Peptide Business Overview Table 72. Chinese Peptide Host Defense Peptides (HDPs) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Chinese Peptide Host Defense Peptides (HDPs) Product Portfolio Table 74. Chinese Peptide Recent Development Table 75. Sunsmile Company Information Table 76. Sunsmile Business Overview Table 77. Sunsmile Host Defense Peptides (HDPs) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Sunsmile Host Defense Peptides (HDPs) Product Portfolio Table 79. Sunsmile Recent Development Table 80. Ruixing Biotechnology Company Information Table 81. Ruixing Biotechnology Business Overview Table 82. Ruixing Biotechnology Host Defense Peptides (HDPs) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Ruixing Biotechnology Host Defense Peptides (HDPs) Product Portfolio Table 84. Ruixing Biotechnology Recent Development Table 85. Phoenix Biotech Company Information Table 86. Phoenix Biotech Business Overview Table 87. Phoenix Biotech Host Defense Peptides (HDPs) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Phoenix Biotech Host Defense Peptides (HDPs) Product Portfolio Table 89. Phoenix Biotech Recent Development Table 90. Ontores Company Information Table 91. Ontores Business Overview Table 92. Ontores Host Defense Peptides (HDPs) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Ontores Host Defense Peptides (HDPs) Product Portfolio Table 94. Ontores Recent Development Table 95. Novabiotics Company Information Table 96. Novabiotics Business Overview Table 97. Novabiotics Host Defense Peptides (HDPs) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Novabiotics Host Defense Peptides (HDPs) Product Portfolio Table 99. Novabiotics Recent Development Table 100. Hycult Biotech Company Information Table 101. Hycult Biotech Business Overview Table 102. Hycult Biotech Host Defense Peptides (HDPs) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Hycult Biotech Host Defense Peptides (HDPs) Product Portfolio Table 104. Hycult Biotech Recent Development Table 105. Glam Technology Company Information Table 106. Glam Technology Business Overview Table 107. Glam Technology Host Defense Peptides (HDPs) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Glam Technology Host Defense Peptides (HDPs) Product Portfolio Table 109. Glam Technology Recent Development Table 110. GenScript Company Information Table 111. GenScript Business Overview Table 112. GenScript Host Defense Peptides (HDPs) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. GenScript Host Defense Peptides (HDPs) Product Portfolio Table 114. GenScript Recent Development Table 115. AnaSpec Company Information Table 116. AnaSpec Business Overview Table 117. AnaSpec Host Defense Peptides (HDPs) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. AnaSpec Host Defense Peptides (HDPs) Product Portfolio Table 119. AnaSpec Recent Development Table 120. AMP Biotech Company Information Table 121. AMP Biotech Business Overview Table 122. AMP Biotech Host Defense Peptides (HDPs) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. AMP Biotech Host Defense Peptides (HDPs) Product Portfolio Table 124. AMP Biotech Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Host Defense Peptides (HDPs) Distributors List Table 128. Host Defense Peptides (HDPs) Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Host Defense Peptides (HDPs) Product Image Figure 2. Global Host Defense Peptides (HDPs) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Host Defense Peptides (HDPs) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Host Defense Peptides (HDPs) Sales (2021-2032) & (K Units) Figure 5. Global Host Defense Peptides (HDPs) Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Host Defense Peptides (HDPs) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Plant Defense Peptides Image Figure 10. Bacterial Defense Peptides Image Figure 11. Animal Defense Peptides Image Figure 12. Global Host Defense Peptides (HDPs) Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Host Defense Peptides (HDPs) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Host Defense Peptides (HDPs) Sales Volume Share by Type (2021-2032) Figure 15. Global Host Defense Peptides (HDPs) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Host Defense Peptides (HDPs) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Host Defense Peptides (HDPs) Sales Value Share by Type (2021-2032) Figure 18. Pharmaceuticals Image Figure 19. Feed Additives Image Figure 20. Others Image Figure 21. Global Host Defense Peptides (HDPs) Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Host Defense Peptides (HDPs) Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Host Defense Peptides (HDPs) Sales Volume Share by Application (2021-2032) Figure 24. Global Host Defense Peptides (HDPs) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Host Defense Peptides (HDPs) Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Host Defense Peptides (HDPs) Sales Value Share by Application (2021-2032) Figure 27. Global Host Defense Peptides (HDPs) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Host Defense Peptides (HDPs) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Host Defense Peptides (HDPs) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Host Defense Peptides (HDPs) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Host Defense Peptides (HDPs) Sales Value (2021-2032) & (US$ Million) Figure 32. North America Host Defense Peptides (HDPs) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Host Defense Peptides (HDPs) Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Host Defense Peptides (HDPs) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Host Defense Peptides (HDPs) Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Host Defense Peptides (HDPs) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Host Defense Peptides (HDPs) Sales Value (2021-2032) & (US$ Million) Figure 38. South America Host Defense Peptides (HDPs) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Host Defense Peptides (HDPs) Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Host Defense Peptides (HDPs) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Host Defense Peptides (HDPs) Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Host Defense Peptides (HDPs) Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Plant Defense Peptides
  • Bacterial Defense Peptides
  • Animal Defense Peptides
Applications
  • Pharmaceuticals
  • Feed Additives
  • Others
Companies covered
  • Zhongnong Yingtai Biotechnology
  • Chinese Peptide
  • Sunsmile
  • Ruixing Biotechnology
  • Phoenix Biotech
  • Ontores
  • Novabiotics
  • Hycult Biotech
  • Glam Technology
  • GenScript
  • AnaSpec
  • AMP Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Host Defense Peptides (HDPs) Sales Value (2021-2032)
  4. 1.2.2 Global Host Defense Peptides (HDPs) Sales Volume (2021-2032)
  5. 1.2.3 Global Host Defense Peptides (HDPs) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Host Defense Peptides (HDPs) Market Dynamics
  1. 2.1 Host Defense Peptides (HDPs) Industry Trends
  2. 2.2 Host Defense Peptides (HDPs) Industry Drivers
  3. 2.3 Host Defense Peptides (HDPs) Industry Opportunities and Challenges
  4. 2.4 Host Defense Peptides (HDPs) Industry Restraints
3 Host Defense Peptides (HDPs) Market by Company
  1. 3.1 Global Host Defense Peptides (HDPs) Company Revenue Ranking in 2025
  2. 3.2 Global Host Defense Peptides (HDPs) Revenue by Company (2021-2026)
  3. 3.3 Global Host Defense Peptides (HDPs) Sales Volume by Company (2021-2026)
  4. 3.4 Global Host Defense Peptides (HDPs) Average Price by Company (2021-2026)
  5. 3.5 Global Host Defense Peptides (HDPs) Company Ranking (2024-2026)
  6. 3.6 Global Host Defense Peptides (HDPs) Company Manufacturing Base and Headquarters
  7. 3.7 Global Host Defense Peptides (HDPs) Company Product Type and Application
  8. 3.8 Global Host Defense Peptides (HDPs) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Host Defense Peptides (HDPs) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Host Defense Peptides (HDPs) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Host Defense Peptides (HDPs) Market by Type
  1. 4.1 Host Defense Peptides (HDPs) Type Introduction
  2. 4.1.1 Plant Defense Peptides
  3. 4.1.2 Bacterial Defense Peptides
  4. 4.1.3 Animal Defense Peptides
  5. 4.2 Global Host Defense Peptides (HDPs) Sales Volume by Type
  6. 4.2.1 Global Host Defense Peptides (HDPs) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Host Defense Peptides (HDPs) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Host Defense Peptides (HDPs) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Host Defense Peptides (HDPs) Sales Value by Type
  10. 4.3.1 Global Host Defense Peptides (HDPs) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Host Defense Peptides (HDPs) Sales Value by Type (2021-2032)
  12. 4.3.3 Global Host Defense Peptides (HDPs) Sales Value Share by Type (2021-2032)
5 Host Defense Peptides (HDPs) Market by Application
  1. 5.1 Host Defense Peptides (HDPs) Application Introduction
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Feed Additives
  4. 5.1.3 Others
  5. 5.2 Global Host Defense Peptides (HDPs) Sales Volume by Application
  6. 5.2.1 Global Host Defense Peptides (HDPs) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Host Defense Peptides (HDPs) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Host Defense Peptides (HDPs) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Host Defense Peptides (HDPs) Sales Value by Application
  10. 5.3.1 Global Host Defense Peptides (HDPs) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Host Defense Peptides (HDPs) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Host Defense Peptides (HDPs) Sales Value Share by Application (2021-2032)
6 Host Defense Peptides (HDPs) Regional Sales and Value Analysis
  1. 6.1 Global Host Defense Peptides (HDPs) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Host Defense Peptides (HDPs) Sales by Region (2021-2032)
  3. 6.2.1 Global Host Defense Peptides (HDPs) Sales by Region: 2021-2026
  4. 6.2.2 Global Host Defense Peptides (HDPs) Sales by Region (2027-2032)
  5. 6.3 Global Host Defense Peptides (HDPs) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Host Defense Peptides (HDPs) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Host Defense Peptides (HDPs) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Host Defense Peptides (HDPs) Sales Value by Region (2027-2032)
  9. 6.5 Global Host Defense Peptides (HDPs) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Host Defense Peptides (HDPs) Sales Value (2021-2032)
  12. 6.6.2 North America Host Defense Peptides (HDPs) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Host Defense Peptides (HDPs) Sales Value (2021-2032)
  15. 6.7.2 Europe Host Defense Peptides (HDPs) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Host Defense Peptides (HDPs) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Host Defense Peptides (HDPs) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Host Defense Peptides (HDPs) Sales Value (2021-2032)
  21. 6.9.2 South America Host Defense Peptides (HDPs) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Host Defense Peptides (HDPs) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Host Defense Peptides (HDPs) Sales Value Share by Country, 2025 VS 2032
7 Host Defense Peptides (HDPs) Country-level Sales and Value Analysis
  1. 7.1 Global Host Defense Peptides (HDPs) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Host Defense Peptides (HDPs) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Host Defense Peptides (HDPs) Sales by Country (2021-2032)
  4. 7.3.1 Global Host Defense Peptides (HDPs) Sales by Country (2021-2026)
  5. 7.3.2 Global Host Defense Peptides (HDPs) Sales by Country (2027-2032)
  6. 7.4 Global Host Defense Peptides (HDPs) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Host Defense Peptides (HDPs) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Host Defense Peptides (HDPs) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Host Defense Peptides (HDPs) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Host Defense Peptides (HDPs) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Host Defense Peptides (HDPs) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhongnong Yingtai Biotechnology
  2. 8.1.1 Zhongnong Yingtai Biotechnology Company Information
  3. 8.1.2 Zhongnong Yingtai Biotechnology Business Overview
  4. 8.1.3 Zhongnong Yingtai Biotechnology Host Defense Peptides (HDPs) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhongnong Yingtai Biotechnology Host Defense Peptides (HDPs) Product Portfolio
  6. 8.1.5 Zhongnong Yingtai Biotechnology Recent Developments
  7. 8.2 Chinese Peptide
  8. 8.2.1 Chinese Peptide Company Information
  9. 8.2.2 Chinese Peptide Business Overview
  10. 8.2.3 Chinese Peptide Host Defense Peptides (HDPs) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Chinese Peptide Host Defense Peptides (HDPs) Product Portfolio
  12. 8.2.5 Chinese Peptide Recent Developments
  13. 8.3 Sunsmile
  14. 8.3.1 Sunsmile Company Information
  15. 8.3.2 Sunsmile Business Overview
  16. 8.3.3 Sunsmile Host Defense Peptides (HDPs) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sunsmile Host Defense Peptides (HDPs) Product Portfolio
  18. 8.3.5 Sunsmile Recent Developments
  19. 8.4 Ruixing Biotechnology
  20. 8.4.1 Ruixing Biotechnology Company Information
  21. 8.4.2 Ruixing Biotechnology Business Overview
  22. 8.4.3 Ruixing Biotechnology Host Defense Peptides (HDPs) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ruixing Biotechnology Host Defense Peptides (HDPs) Product Portfolio
  24. 8.4.5 Ruixing Biotechnology Recent Developments
  25. 8.5 Phoenix Biotech
  26. 8.5.1 Phoenix Biotech Company Information
  27. 8.5.2 Phoenix Biotech Business Overview
  28. 8.5.3 Phoenix Biotech Host Defense Peptides (HDPs) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Phoenix Biotech Host Defense Peptides (HDPs) Product Portfolio
  30. 8.5.5 Phoenix Biotech Recent Developments
  31. 8.6 Ontores
  32. 8.6.1 Ontores Company Information
  33. 8.6.2 Ontores Business Overview
  34. 8.6.3 Ontores Host Defense Peptides (HDPs) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Ontores Host Defense Peptides (HDPs) Product Portfolio
  36. 8.6.5 Ontores Recent Developments
  37. 8.7 Novabiotics
  38. 8.7.1 Novabiotics Company Information
  39. 8.7.2 Novabiotics Business Overview
  40. 8.7.3 Novabiotics Host Defense Peptides (HDPs) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Novabiotics Host Defense Peptides (HDPs) Product Portfolio
  42. 8.7.5 Novabiotics Recent Developments
  43. 8.8 Hycult Biotech
  44. 8.8.1 Hycult Biotech Company Information
  45. 8.8.2 Hycult Biotech Business Overview
  46. 8.8.3 Hycult Biotech Host Defense Peptides (HDPs) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hycult Biotech Host Defense Peptides (HDPs) Product Portfolio
  48. 8.8.5 Hycult Biotech Recent Developments
  49. 8.9 Glam Technology
  50. 8.9.1 Glam Technology Company Information
  51. 8.9.2 Glam Technology Business Overview
  52. 8.9.3 Glam Technology Host Defense Peptides (HDPs) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Glam Technology Host Defense Peptides (HDPs) Product Portfolio
  54. 8.9.5 Glam Technology Recent Developments
  55. 8.10 GenScript
  56. 8.10.1 GenScript Company Information
  57. 8.10.2 GenScript Business Overview
  58. 8.10.3 GenScript Host Defense Peptides (HDPs) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 GenScript Host Defense Peptides (HDPs) Product Portfolio
  60. 8.10.5 GenScript Recent Developments
  61. 8.11 AnaSpec
  62. 8.11.1 AnaSpec Company Information
  63. 8.11.2 AnaSpec Business Overview
  64. 8.11.3 AnaSpec Host Defense Peptides (HDPs) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 AnaSpec Host Defense Peptides (HDPs) Product Portfolio
  66. 8.11.5 AnaSpec Recent Developments
  67. 8.12 AMP Biotech
  68. 8.12.1 AMP Biotech Company Information
  69. 8.12.2 AMP Biotech Business Overview
  70. 8.12.3 AMP Biotech Host Defense Peptides (HDPs) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 AMP Biotech Host Defense Peptides (HDPs) Product Portfolio
  72. 8.12.5 AMP Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Host Defense Peptides (HDPs) Value Chain Analysis
  2. 9.1.1 Host Defense Peptides (HDPs) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Host Defense Peptides (HDPs) Sales Mode & Process
  6. 9.2 Host Defense Peptides (HDPs) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Host Defense Peptides (HDPs) Distributors
  9. 9.2.3 Host Defense Peptides (HDPs) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst